GEN1047 for Solid Tumors - First in Human (FIH) Trial
Genmab
Genmab
Conjupro Biotherapeutics, Inc.
Fusion Pharmaceuticals Inc.
Pfizer
Nuvation Bio Inc.
Tempus AI
Incyte Corporation
Actym Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
University of Virginia
Hutchmed
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Dana-Farber Cancer Institute
Pfizer
NextCure, Inc.
Black Diamond Therapeutics, Inc.
Elevation Oncology
Valerio Therapeutics
Deciphera Pharmaceuticals, LLC
Deciphera Pharmaceuticals, LLC
Aminex Therapeutics, Inc.
Five Prime Therapeutics, Inc.
Tango Therapeutics, Inc.
NantCell, Inc.
Medikine, Inc.
Ikena Oncology
Haihe Biopharma Co., Ltd.
CytomX Therapeutics
Atreca, Inc.
Fusion Pharmaceuticals Inc.
Leap Therapeutics, Inc.
Pfizer
pharmaand GmbH
Fate Therapeutics
Hoffmann-La Roche
Incyte Corporation
Tesaro, Inc.
National Institutes of Health Clinical Center (CC)
MacroGenics
University of Pennsylvania
Novartis
Dr. Horst Schmidt Klinik GmbH
ExcellaBio LLC
Syros Pharmaceuticals
Seagen Inc.
AIDS Malignancy Consortium
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)